Fabrizio Cantini

13.6k total citations · 2 hit papers
173 papers, 7.6k citations indexed

About

Fabrizio Cantini is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Fabrizio Cantini has authored 173 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Rheumatology, 42 papers in Immunology and 41 papers in Hematology. Recurrent topics in Fabrizio Cantini's work include Rheumatoid Arthritis Research and Therapies (69 papers), Spondyloarthritis Studies and Treatments (67 papers) and Autoimmune and Inflammatory Disorders Research (32 papers). Fabrizio Cantini is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (69 papers), Spondyloarthritis Studies and Treatments (67 papers) and Autoimmune and Inflammatory Disorders Research (32 papers). Fabrizio Cantini collaborates with scholars based in Italy, United States and Spain. Fabrizio Cantini's co-authors include Carlo Salvarani, Luigi Boiardi, Gene G. Hunder, Laura Niccoli, Ignazio Olivieri, Angela Padula, Delia Goletti, Carlotta Nannini, Pierluigi Macchioni and Emanuele Cassarà and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Annals of Internal Medicine.

In The Last Decade

Fabrizio Cantini

170 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Polymyalgia Rheumatica and Giant-Cell Arteritis

2002 903 citations Carlo Salvarani, Fabrizio Cantini et al. profile →
Polymyalgia rheumatica and giant-cell arteritis

2008 458 citations Carlo Salvarani, Fabrizio Cantini et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fabrizio Cantini Italy	51	4.8k	3.1k	1.8k	1.3k	1.0k	173	7.6k
Xavier Puéchal France	46	3.3k 0.7×	3.0k 0.9×	914 0.5×	897 0.7×	564 0.5×	213	7.1k
Benjamin Terrier France	45	2.2k 0.5×	2.4k 0.8×	1.4k 0.8×	889 0.7×	380 0.4×	289	6.1k
T. Papo France	44	2.1k 0.4×	1.5k 0.5×	1.6k 0.9×	463 0.4×	1.2k 1.1×	245	6.4k
Gerard Espinosa Spain	53	5.4k 1.1×	1.2k 0.4×	1.8k 1.0×	313 0.2×	2.4k 2.3×	340	8.8k
Pilar Brito‐Zerón Spain	47	3.3k 0.7×	1.1k 0.4×	1.9k 1.0×	332 0.3×	1.1k 1.1×	120	8.8k
Ulrich Specks United States	62	5.0k 1.0×	10.2k 3.2×	2.3k 1.3×	2.9k 2.3×	602 0.6×	302	13.9k
Carlos García‐Porrúa Spain	45	4.2k 0.9×	3.8k 1.2×	1.6k 0.9×	1.0k 0.8×	363 0.4×	154	6.9k
Lorraine Harper United Kingdom	48	2.7k 0.6×	5.7k 1.8×	2.0k 1.1×	2.0k 1.6×	288 0.3×	192	8.3k
Alfred Mahr France	59	6.4k 1.3×	10.5k 3.4×	1.6k 0.9×	2.5k 2.0×	638 0.6×	181	13.3k
Mahboob U. Rahman United States	38	3.8k 0.8×	701 0.2×	1.4k 0.8×	912 0.7×	1.6k 1.6×	85	5.8k

Countries citing papers authored by Fabrizio Cantini

Since Specialization

Citations

This map shows the geographic impact of Fabrizio Cantini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrizio Cantini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrizio Cantini more than expected).

Fields of papers citing papers by Fabrizio Cantini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabrizio Cantini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrizio Cantini. The network helps show where Fabrizio Cantini may publish in the future.

Co-authorship network of co-authors of Fabrizio Cantini

This figure shows the co-authorship network connecting the top 25 collaborators of Fabrizio Cantini. A scholar is included among the top collaborators of Fabrizio Cantini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabrizio Cantini. Fabrizio Cantini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gentileschi, Stefano, Carla Gaggiano, Arianna Damiani, et al.. (2024). Secukinumab for the Treatment of Axial Spondyloarthritis: Long-Term Real-Life Data from Five Italian Referral Centers. Journal of Personalized Medicine. 14(11). 1105–1105. 2 indexed citations

Cantini, Fabrizio, Antonio Marchesoni, Lucia Novelli, et al.. (2024). Effects of upadacitinib on enthesitis in patients with psoriatic arthritis: a post hoc analysis of SELECT-PsA 1 and 2 trials. Lara D. Veeken. 63(11). 3146–3154. 2 indexed citations

Petruccioli, Elisa, Linda Petrone, Saeid Najafi Fard, et al.. (2023). Alternative biomarkers of tuberculosis infection in patients with immune-mediated inflammatory diseases. Frontiers in Medicine. 10. 1271632–1271632.

Francesconi, Paolo, et al.. (2021). COVID-19 epidemiology in rheumatic diseases in Tuscany: A case-control study. Joint Bone Spine. 88(3). 105131–105131. 7 indexed citations

Cantini, Fabrizio, Corrado Blandizzi, Laura Niccoli, Linda Petrone, & Delia Goletti. (2020). Systematic review on tuberculosis risk in patients with rheumatoid arthritis receiving inhibitors of Janus Kinases. Expert Opinion on Drug Safety. 19(7). 861–872. 28 indexed citations

Cantini, Fabrizio, Delia Goletti, Linda Petrone, et al.. (2020). Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review. Drugs. 80(18). 1929–1946. 57 indexed citations

Cantini, Fabrizio, Laura Niccoli, Giulia Franchi, Arianna Damiani, & Maurizio Benucci. (2020). The Nocebo Effect in Rheumatology: An Unexplored Issue.. PubMed. 22(3). 185–190. 4 indexed citations

Benucci, Maurizio, Arianna Damiani, Francesca Li Gobbi, et al.. (2020). <p>Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical Data</p>. Therapeutics and Clinical Risk Management. Volume 16. 287–297. 4 indexed citations

Esposti, Luca Degli, et al.. (2019). <p>Therapeutic strategies utilization and resource consumption in patients treated for psoriatic arthritis: findings from a real-world analysis in an Italian setting</p>. Patient Preference and Adherence. Volume 13. 187–194. 3 indexed citations

10.

Cantini, Fabrizio, Maurizio Benucci, Francesca Li Gobbi, Giulia Franchi, & Laura Niccoli. (2019). Biosimilars for the treatment of psoriatic arthritis. Expert Review of Clinical Immunology. 15(11). 1195–1203. 3 indexed citations

11.

Cantini, Fabrizio & Maurizio Benucci. (2018). Focus on biosimilar etanercept – bioequivalence and interchangeability. Biologics. Volume 12. 87–95. 14 indexed citations

12.

Niccoli, Laura, Carlotta Nannini, Corrado Blandizzi, et al.. (2018). Personalization of biologic therapy in patients with rheumatoid arthritis: less frequently accounted choice-driving variables. Therapeutics and Clinical Risk Management. Volume 14. 2097–2111. 4 indexed citations

13.

Cantini, Fabrizio, Carlotta Nannini, Laura Niccoli, et al.. (2017). Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics. Mediators of Inflammation. 2017. 1–15. 104 indexed citations

14.

Lubrano, Ennio, Fabrizio Cantini, Alessandro Mathieu, et al.. (2017). A national survey on the management of psoriatic arthritis using the Delphi method.. PubMed. 35(2). 214–220. 3 indexed citations

15.

Olivieri, Ignazio, Paolo Angelo Cortesi, Carlo Salvarani, et al.. (2016). Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: the extension of the Psoriatic Arthritis Cost Evaluation (PACE) study.. PubMed. 34(1). 68–75. 11 indexed citations

16.

Pulsatelli, Lia, Giuseppe Peri, Pierluigi Macchioni, et al.. (2010). Serum levels of long pentraxin PTX3 in patients with polymyalgia rheumatica.. PubMed. 28(5). 756–8. 14 indexed citations

17.

Cantini, Fabrizio, Laura Niccoli, Carlotta Nannini, et al.. (2009). Criteria, Frequency, and Duration of Clinical Remission in Psoriatic Arthritis Patients with Peripheral Involvement Requiring Second-line Drugs. PubMed. 83(0). 78–80. 14 indexed citations

18.

Salvarani, Carlo, Fabrizio Cantini, Ignazio Olivieri, et al.. (2000). Corticosteroid injections in polymyalgia rheumatica: a double-blind, prospective, randomized, placebo controlled study.. PubMed. 27(6). 1470–6. 35 indexed citations

19.

Olivieri, Ignazio, Libero Barozzi, Angela Padula, et al.. (1998). Retrocalcaneal bursitis in spondyloarthropathy: assessment by ultrasonography and magnetic resonance imaging.. PubMed. 25(7). 1352–7. 58 indexed citations

20.

Bellandi, Francesco, et al.. (1995). Effectiveness of intravenous propafenone for conversion of recent‐onset atrial fibrillation: A placebo‐controlled study. Clinical Cardiology. 18(11). 631–634. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact